Growth Metrics

Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn 0.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.23%
Dec 31, 2025 -1.18%
Sep 30, 2025 -3.41%
Jun 30, 2025 -1.14%
Mar 31, 2025 -0.20%
Dec 31, 2024 2.54%
Mar 31, 2024 2,356,300.00%
Dec 31, 2023 31.50%
Mar 31, 2023 -99.88%
Dec 31, 2022 1,725.67%
Sep 30, 2022 -88.63%
Jun 30, 2022 -76.02%
Mar 31, 2022 124.35%
Dec 31, 2021 124.02%
Sep 30, 2021 148.52%
Jun 30, 2021 42.20%
Mar 31, 2021 29.05%
Dec 31, 2020 42.43%
Sep 30, 2020 29.50%
Jun 30, 2020 29.65%
Mar 31, 2020 -16.85%
Dec 31, 2019 -21.24%
Sep 30, 2019 32.94%
Jun 30, 2019 27.49%
Mar 31, 2019 9.54%
Dec 31, 2018 39.86%
Sep 30, 2018 -19.05%
Jun 30, 2018 -18.72%
Mar 31, 2018 -18.55%
Dec 31, 2017 -37.84%
Sep 30, 2017 -56.01%
Jun 30, 2017 -55.42%
Mar 31, 2017 -41.50%
Dec 31, 2016 -36.39%
Sep 30, 2016 0.99%
Jun 30, 2016 438.93%
Mar 31, 2016 82.84%
Dec 31, 2015 -23.38%
Sep 30, 2015 46.79%
Jun 30, 2015 -72.46%
Mar 31, 2015 -38.95%
Dec 31, 2014 33.58%
Sep 30, 2014 -35.43%
Jun 30, 2014 -42.69%
Mar 31, 2014 -59.29%
Dec 31, 2013 -58.39%
Dec 31, 2012 -67.45%